The ROE as of September 2024 (TTM) for Theralink Technologies, Inc. (THER) is -41.95%

According to Theralink Technologies, Inc.’s latest financial reports and current stock price. The company's current ROE is -41.95%. This represents a change of 2.61% compared to the average of -1.55% of the last 4 quarters.

Theralink Technologies, Inc. (THER) Historical ROE (quarterly & annually)

How has THER ROE performed in the past?

The mean historical ROE of Theralink Technologies, Inc. over the last ten years is 102.95%. The current -41.95% ROE has changed -140.75% with respect to the historical average. Over the past ten years (40 quarters), THER's ROE was at its highest in in the August 2015 quarter at 475.53%. The ROE was at its lowest in in the December 2020 quarter at -609.58%.

Theralink Technologies, Inc. (THER) ROE by Quarter and Year

Discovering the peaks and valleys of Theralink Technologies, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Theralink Technologies, Inc. (THER) Average ROE

How has THER ROE performed in the past?

The current ROE of Theralink Technologies, Inc. (THER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Theralink Technologies, Inc. (THER) ROE vs. Peers

How is THER’s ROE compared to its peers?

Theralink Technologies, Inc.’s ROE is less than Adhera Therapeutics, Inc. (0%), less than GB Sciences, Inc. (17.25%), less than SciSparc Ltd. (27.88%), greater than Creative Medical Technology Holdings, Inc. (-87.48%), greater than Regen BioPharma, Inc. (-58.37%), less than Enzolytics Inc. (16.82%), less than Sonnet BioTherapeutics Holdings, Inc. (93.13%), greater than Inhibikase Therapeutics, Inc. (-398.33%), greater than Sio Gene Therapies Inc. (-194.17%), greater than Kaleido Biosciences, Inc. (-13.69%), less than Tempest Therapeutics, Inc. (0%), greater than Lexaria Bioscience Corp. (-201.10%), less than Navidea Biopharmaceuticals, Inc. (0%), greater than ZyVersa Therapeutics, Inc. (-82.80%), greater than Biodexa Pharmaceuticals Plc (-63.06%), greater than Oncorus, Inc. (-172.51%), greater than null (-141.90%), greater than null (-130.61%),

Build a custom stock screener for Theralink Technologies, Inc. (THER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theralink Technologies, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theralink Technologies, Inc. (THER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theralink Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.